<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: Genetic and epidemiological studies suggest an association between <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Both are polygenic multifactorial disorders characterised by <z:hpo ids='HP_0006279'>beta cell dysfunction</z:hpo> and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Our aim was to investigate whether common genetic variants that have previously been associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or related phenotypes would also confer risk for <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIALS AND METHODS: In 1,881 unrelated pregnant Scandinavian women (649 women with <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus, 1,232 non-diabetic control subjects) we genotyped the transcription factor 7-like 2 (TCF7L2 rs7903146), adiponectin (ADIPOQ +276G &gt; T), peroxisome-proliferator activated receptor, gamma 2 (PPARG Pro12Ala), PPARG-coactivator, 1 alpha (PPARGC1A Gly482Ser), forkhead box C2 (FOXC2 -512C &gt; T) and beta3-adrenergic receptor (ADRB3 Trp64Arg) polymorphisms using TaqMan allelic discrimination assay or RFLP </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The CC, CT and TT genotype frequencies of the TCF7L2 rs7903146 variant differed significantly between women with <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus and control women (46.3, 43.6 and 10.1% vs 58.5, 35.3 and 6.2%, p = 3.7 x 10(-6), corrected p value [Pc] for multiple testing Pc = 2.2 x 10(-5)) </plain></SENT>
<SENT sid="5" pm="."><plain>The T-allele was associated with an increased risk of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (odds ratio 1.49 [95% CI 1.28-1.75], p = 4.9 x 10(-7) [Pc = 2.8 x 10(-6)]) </plain></SENT>
<SENT sid="6" pm="."><plain>Compared with <z:mp ids='MP_0002169'>wild-type</z:mp> CC-genotype carriers, heterozygous (CT-genotype) and homozygous (TT-genotype) carriers had a 1.6-fold (95% CI 1.26-1.93, p = 3.7 x 10(-5) [Pc = 0.0002]) and a 2.1-fold (95% CI 1.41-2.99, p = 0.0001 [Pc = 0.0008]) increased risk of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>The other polymorphisms studied were not significantly associated with <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (ADIPOQ +276G &gt; T: 1.17 [1.01-1.36], p = 0.039 [Pc = 0.23]; PPARG Pro12Ala: 1.06 [0.87-1.29], p = 0.53; PPARGC1A Gly482Ser: 0.96 [0.83-1.10], p = 0.54; FOXC2 -512C &gt; T: 1.01 [0.87-1.16], p = 0.94; and ADRB3 Trp64Arg: 1.22 [0.95-1.56], p = 0.12) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS/INTERPRETATION: The TCF7L2 rs7903146 variant is associated with an increased risk of <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus in Scandinavian women </plain></SENT>
</text></document>